DPP4i vs placebo
Worsening kidney function · CVD (ASCVD, HF, or both)
DPP4i showed no clear difference in worsening renal function compared with placebo (low certainty).
1 finding from 1 review
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes onlyOR 1.08 [0.88, 1.33]1 study · 16492 participantsLow